View in EDS HTML Full Text PDF Full Text

Assessment of anxiety/depression among cancer patients before and during the COVID-19 pandemic.

Saved in:
Bibliographic Details
Title: Assessment of anxiety/depression among cancer patients before and during the COVID-19 pandemic.
Authors: Adzrago, David (AUTHOR), Sulley, Saanie (AUTHOR), Tagoe, Ishmael (AUTHOR), Ormiston, Cameron K. (AUTHOR), Odame, Emmanuel A. (AUTHOR), Mamudu, Lohuwa (AUTHOR), Williams, Faustine (AUTHOR)
Source: Psycho-Oncology. Oct2022, Vol. 31 Issue 10, p1681-1691. 11p. 5 Charts.
Abstract: Objective: To assess differences in the prevalence of anxiety/depression symptoms among cancer patients before (2019) and during the COVID-19 pandemic (2020); and the associations between anxiety/depression and sociodemographic and health behavior factors among cancer patients before and during the pandemic.Methods: We analyzed data from the 2019 (n= 856) and 2020 (n= 626) Health Information National Trends Survey, a nationally representative survey of US adults aged ≥18 years. Only adults with a cancer diagnosis were used in the analyses. Anxiety/depression was assessed using the Patient Health Questionnaire-4 (low/none [0-2], mild [3-5], moderate [6-8], and severe [9-12]) and dichotomized as low/none and current anxiety/depression (mild/moderate/severe). Multivariate analysis was performed.Results: The prevalence of anxiety/depression symptoms among cancer patients was 32.7% before the COVID-19 pandemic and 31.1% during the pandemic. The odds of anxiety/depression among patients with fair/poor health status was higher during the pandemic relative to before (before: [Odds Ratio] OR=1.85 vs during: OR=3.89). Participants aged 50-64 years (before: OR=0.29, CI [95% Confidence Interval]=0.11-0.76; during: OR=0.33, CI=0.11-0.97) and ≥65 years (before: OR= 0.13, CI=0.05-0.34; during: OR=0.18, CI=0.07-0.47) had lower odds of anxiety/depression before and during the pandemic compared to those aged 35-49 years. Hispanics/Latinos had higher odds of anxiety/depression (OR=2.70, CI=1.11-6.57) before the pandemic and lower odds of anxiety/depression during the pandemic (OR=0.2, CI=0.05-1.01) compared to non-Hispanic Whites. Those who completed high school (before: OR=0.08, CI=0.01-0.42), some college (before: OR=0.10, CI=0.02-0.42), ≥college degree had lower odds of anxiety/depression symptoms (before: OR= 0.05, 95% CI= 0.01-0.26; during: OR= 0.06, CI= 0.01-0.61) compared to those with less than a high school education.Conclusion: Our results suggest the need to increase the provision of mental health services to cancer patients at high risk of developing anxiety/depression symptoms, particularly during public health emergencies, to alleviate further health burdens. This article is protected by copyright. All rights reserved. [ABSTRACT FROM AUTHOR]
Copyright of Psycho-Oncology is the property of Wiley-Blackwell and its content may not be copied or emailed to multiple sites without the copyright holder's express written permission. Additionally, content may not be used with any artificial intelligence tools or machine learning technologies. However, users may print, download, or email articles for individual use. This abstract may be abridged. No warranty is given about the accuracy of the copy. Users should refer to the original published version of the material for the full abstract. (Copyright applies to all Abstracts.)
Database: Psychology and Behavioral Sciences Collection
Full text is not displayed to guests.
Description
Abstract:<bold>Objective: </bold>To assess differences in the prevalence of anxiety/depression symptoms among cancer patients before (2019) and during the COVID-19 pandemic (2020); and the associations between anxiety/depression and sociodemographic and health behavior factors among cancer patients before and during the pandemic.<bold>Methods: </bold>We analyzed data from the 2019 (n= 856) and 2020 (n= 626) Health Information National Trends Survey, a nationally representative survey of US adults aged ≥18 years. Only adults with a cancer diagnosis were used in the analyses. Anxiety/depression was assessed using the Patient Health Questionnaire-4 (low/none [0-2], mild [3-5], moderate [6-8], and severe [9-12]) and dichotomized as low/none and current anxiety/depression (mild/moderate/severe). Multivariate analysis was performed.<bold>Results: </bold>The prevalence of anxiety/depression symptoms among cancer patients was 32.7% before the COVID-19 pandemic and 31.1% during the pandemic. The odds of anxiety/depression among patients with fair/poor health status was higher during the pandemic relative to before (before: [Odds Ratio] OR=1.85 vs during: OR=3.89). Participants aged 50-64 years (before: OR=0.29, CI [95% Confidence Interval]=0.11-0.76; during: OR=0.33, CI=0.11-0.97) and ≥65 years (before: OR= 0.13, CI=0.05-0.34; during: OR=0.18, CI=0.07-0.47) had lower odds of anxiety/depression before and during the pandemic compared to those aged 35-49 years. Hispanics/Latinos had higher odds of anxiety/depression (OR=2.70, CI=1.11-6.57) before the pandemic and lower odds of anxiety/depression during the pandemic (OR=0.2, CI=0.05-1.01) compared to non-Hispanic Whites. Those who completed high school (before: OR=0.08, CI=0.01-0.42), some college (before: OR=0.10, CI=0.02-0.42), ≥college degree had lower odds of anxiety/depression symptoms (before: OR= 0.05, 95% CI= 0.01-0.26; during: OR= 0.06, CI= 0.01-0.61) compared to those with less than a high school education.<bold>Conclusion: </bold>Our results suggest the need to increase the provision of mental health services to cancer patients at high risk of developing anxiety/depression symptoms, particularly during public health emergencies, to alleviate further health burdens. This article is protected by copyright. All rights reserved. [ABSTRACT FROM AUTHOR]
ISSN:10579249
DOI:10.1002/pon.6026